Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 34,568 shares at $55.11 ($1.9M) on 2024-01-17, disclosed to the SEC on 2024-01-18.
Scheduled sale ($1.9M) by HEAD OF R&D, COO-NOVITIUM Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.63 | 5,000 | $278K | 14.6% |
| 2 | $55.11 | 10,000 | $551K | 28.8% |
| 3 | $55.30 | 9,784 | $541K | 28.3% |
| 4 | $55.30 | 9,784 | $541K | 28.3% |
| Total | $55.29 avg | 34,568 | $1.9M | 100% |
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |